DataMEDS AI, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MEDS | YI | AIML.CN | APUS | ALC.AX | AHE.AX | |
|---|---|---|---|---|---|---|
| Market cap | 7.72M | 26.39M | 13.43M | 4.41M | 155.23M | 8.93M |
| P/E (TTM) | — | 0.3 | — | — | — | — |
| Forward P/E | — | 21.4 | — | — | 34.6 | — |
| Price/book | -0.2 | -0.2 | -6.4 | 4.5 | 1.7 | -3.5 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −95.68% | −30.07% | 0.00% | −88.39% | +15.38% | −52.00% |
| Today | −17.22% | −0.66% | −10.00% | −1.68% | +9.52% | +16.67% |
The closest companies by business and industry (Medical Distribution). Prices may be delayed up to 20 min.
Latest news
All MEDS news ›DataMEDS AI Announces Termination of Second Amended and Restated Letter of Intent
As a result of the termination of the 2nd LOI, DataMEDS will no longer be issuing any shares related to the 2nd LOI. DataMEDS confirms that its exclusive license with REBOOT for the management of GLP-1 users, dated October 13, 2026,…
Announcing Hebbia's Partnership with Datasite
Hebbia now integrates with Datasite, giving deal teams direct access to their data rooms in an AI-native platform. A data room contains the documents a deal team reviews most closely, including CIMs, financials, contracts, and disclosure…
Israeli digital health company TailorMed acquired in $250 million deal
Private equity firm GrowthCurve is taking a controlling stake in the company, which connects patients with financial and medical support programs across the United States. Most existing shareholders are expected to sell their holdings.…
ADDL - New Name & Website
Autism & Developmental Disabilities Lab Simon Fraser University We are excited to announce a change to our name! We have changed our name to the Autism and Developmental Disabilities Lab, replacing the term "disorders" in our old name with…
TailorMed Secures Majority Private Equity Investment: Expanding AI-Driven Pharmacy Access
HIT Consultant What You Should Know - Medication access and financial assistance technology leader TailorMed announced that it has secured a majority private equity investment from New York-based GrowthCurve C
Datakosa Wins USD 2.47 Million AI Automation Order from US-Based Hermes Networks
02 Nov 2026, 09:19 PM IST Equity Bulls Datakosa Limited, formerly Bodhtree Consulting Limited, has received a work order from Hermes Networks Inc., USA, for AI-led automation, integration and implementation services. The order is valued at…
GrowthCurve Capital takes majority stake in medication access platform TailorMed
TailorMed runs a platform that helps patients access, afford and stay on prescribed medications. Permira hires former S&P Global CEO Douglas Peterson as senior adviser 1 hour ago · 2 mins read OpenGate Capital completes carve-out of Maersk…
Datavault AI Seeks 19.9% Stake in DataMEDS Through Licensing Deal
PHILADELPHIA, PA — Datavault AI Inc. (Nasdaq: DVLT) is seeking a 19.9% ownership stake in DataMEDS AI Inc. (Nasdaq: MEDS) in exchange for expanded rights to its healthcare data technology, a proposed transaction that would give the…
TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now?
With the earnings season in full swing, investors will be closely tracking both companies' performance and growth prospects. Tempus AI's expanding AI-powered diagnostic capabilities and Doximity's digital healthcare platform and…
Analyzing OneMedNet (ONMD) and The Competition
Posted by Defense World Staff on Oct 31st, 2026 OneMedNet (NASDAQ:ONMD – Get Free Report) is one of 93 public companies in the “Healthcare Technology” industry, but how does it compare to its peers? We will compare OneMedNet to similar…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- tradingview.com12
- stocktitan.net10
- stockstotrade.com6
- openpr.com5
- timothysykes.com5
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 87 articles, not a forecast.